Unique ID issued by UMIN | UMIN000034568 |
---|---|
Receipt number | R000039410 |
Scientific Title | The significance of transcutaneous continuous overnight carbon-dioxide trends in COPD (chronic obstructive pulmonary disease) stages |
Date of disclosure of the study information | 2018/10/19 |
Last modified on | 2020/04/20 13:14:52 |
The significance of transcutaneous continuous overnight carbon-dioxide trends in COPD (chronic obstructive pulmonary disease) stages
The significance of transcutaneous continuous overnight CO2 trends in COPD stages
The significance of transcutaneous continuous overnight carbon-dioxide trends in COPD (chronic obstructive pulmonary disease) stages
The significance of transcutaneous continuous overnight CO2 trends in COPD stages
Japan |
COPD(chronic obstructive pulmonary disease)
Pneumology |
Others
NO
To grasp transcutaneous continuous overnight carbon-dioxide trends on GOLD stages of COPD patients.
Others
The measurement of the CO2 concentration in the arterial blood is also accompanied by pain associated with blood test, frequent measurement is not practical. Transcutaneous CO2 monitor has been developed in recent years. We investigate whether the severity in the pulmonary function test of COPD, well-known as GOLD, is correlated to the CO2 concentration using transcutaneous CO2 monitor.
Ratio of more than 55 mmHg of transcutaneous continuous overnight carbon-dioxide trends on GOLD stages of COPD patients.
CAT:The chronic obstructive pulmonary disease Assessment Test questionnaire, EXACT(EXAcerbations of Chronic pulmonary disease Tool), ER-S score(EXACT-Respiratory Symptoms scale), COPD exacerbation frequency
Observational
20 | years-old | <= |
Not applicable |
Male and Female
The patients who have diagnosed COPD by obstruction disorder by lung function examination, chest CT or X-ray examination, and interview.
The patients who cannot exclude obstructive pulmonary disorders other than COPD, and those who do not agree to participate in the study.
50
1st name | Nobuyo |
Middle name | |
Last name | Tamiya |
Kyoto Prefectural University of Medicine
Department of Respiratory medicine
6028566
465 Kajii-cho Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan
075-251-5513
koma@koto.kpu-m.ac.jp
1st name | Nobuyo |
Middle name | |
Last name | Tamiya |
Kyoto Prefectural University of Medicine
Department of Respiratory medicine
6028566
465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan
075-251-5513
koma@koto.kpu-m.ac.jp
Kyoto Prefectural University of Medicine, Department of Respiratory medicine
None
Self funding
Japanese Red Cross Society Kyoto Daini Hospital
Rakuwakai Otowa Hospital
Institutional Review Board of Kyoto Prefectural University of Medicine
465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan
075-251-5337
rinri@koto.kpu-m.ac.jp
NO
京都府立医科大学附属病院(京都府)、京都第二赤十字病院(京都府)、洛和会音羽病院(京都府)
2018 | Year | 10 | Month | 19 | Day |
Unpublished
No longer recruiting
2018 | Year | 10 | Month | 19 | Day |
2018 | Year | 11 | Month | 19 | Day |
2018 | Year | 10 | Month | 19 | Day |
2020 | Year | 03 | Month | 31 | Day |
2020 | Year | 03 | Month | 31 | Day |
To investigate whether CO2 concentration using the transcutaneous CO2 monitor trend is correlated to COPD severity.
2018 | Year | 10 | Month | 19 | Day |
2020 | Year | 04 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039410
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |